October 15, 2024
An Van Gerven Is Appointed President of Pfizer Canada
September 24, 2024
Pfizer Canada and BioNTech Receive Health Canada Approval of Omicron KP.2 Variant Adapted COVID-19 Vaccine
September 19, 2024
ABRYSVO™: Pfizer’s Canada’s Newly Publicly Funded Vaccine a Step Towards National RSV Prevention in Older Adults
No current content.